Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 14

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

Total article views   HTML views PDF downloads Totals
7,595 Dovepress* 7,076+ 1,446 8,522
PubMed Central* 519 206 725
Totals 7,595 1,652 9,247
*Since 19 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
20 2 0 0 8 10

View citations on PubMed Central and Google Scholar